199 related articles for article (PubMed ID: 23475875)
1. Aiming for the outliers: cancer precision medicine through targeting kinases with extreme expression.
Yegnasubramanian S; Maitra A
Cancer Discov; 2013 Mar; 3(3):252-4. PubMed ID: 23475875
[TBL] [Abstract][Full Text] [Related]
2. Outlier kinase expression by RNA sequencing as targets for precision therapy.
Kothari V; Wei I; Shankar S; Kalyana-Sundaram S; Wang L; Ma LW; Vats P; Grasso CS; Robinson DR; Wu YM; Cao X; Simeone DM; Chinnaiyan AM; Kumar-Sinha C
Cancer Discov; 2013 Mar; 3(3):280-93. PubMed ID: 23384775
[TBL] [Abstract][Full Text] [Related]
3. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
4. [Kinase inhibitors and their resistance].
Togashi Y; Nishio K
Nihon Rinsho; 2015 Aug; 73(8):1323-9. PubMed ID: 26281685
[TBL] [Abstract][Full Text] [Related]
5. Targeting protein kinases in cancer therapy: a success?
Pearson MA; Fabbro D
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1113-24. PubMed ID: 15606337
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors.
Huang Z; Lee MH
Curr Pharm Des; 2017 Nov; 23(29):4207-4208. PubMed ID: 29231803
[No Abstract] [Full Text] [Related]
7. Protein kinases as drug targets.
Yli-Kauhaluoma J; Tuominen RK
Curr Top Med Chem; 2011; 11(11):1304. PubMed ID: 21513501
[No Abstract] [Full Text] [Related]
8. Progress and potential impact of RET kinase targeting in cancer.
Mulligan LM
Expert Rev Proteomics; 2016 Jul; 13(7):631-3. PubMed ID: 27337654
[No Abstract] [Full Text] [Related]
9. Protein kinases in cancer: recent findings.
Schenone S
Curr Med Chem; 2011; 18(19):2826. PubMed ID: 21651497
[No Abstract] [Full Text] [Related]
10. Kinase inhibitor conjugates.
Harmsen S; Kok RJ
Curr Pharm Des; 2012; 18(20):2891-900. PubMed ID: 22571658
[TBL] [Abstract][Full Text] [Related]
11. Biochemical mechanisms of resistance to small-molecule protein kinase inhibitors.
Krishnamurty R; Maly DJ
ACS Chem Biol; 2010 Jan; 5(1):121-38. PubMed ID: 20044834
[TBL] [Abstract][Full Text] [Related]
12. Point mutations of protein kinases and individualised cancer therapy.
Davies M; Hennessy B; Mills GB
Expert Opin Pharmacother; 2006 Nov; 7(16):2243-61. PubMed ID: 17059381
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies.
Bagrodia S; Smeal T; Abraham RT
Pigment Cell Melanoma Res; 2012 Nov; 25(6):819-31. PubMed ID: 22883054
[TBL] [Abstract][Full Text] [Related]
14. Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective.
Carlino L; Rastelli G
J Med Chem; 2016 Oct; 59(20):9305-9320. PubMed ID: 27559828
[TBL] [Abstract][Full Text] [Related]
15. Carbazole Derivatives as Kinase-Targeting Inhibitors for Cancer Treatment.
Ceramella J; Iacopetta D; Barbarossa A; Caruso A; Grande F; Bonomo MG; Mariconda A; Longo P; Carmela S; Sinicropi MS
Mini Rev Med Chem; 2020; 20(6):444-465. PubMed ID: 31951166
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase inhibitors: breakthrough medicines and the next generation.
Sawyer TK; Wu JC; Sawyer JR; English JM
Expert Opin Investig Drugs; 2013 Jun; 22(6):675-8. PubMed ID: 23705633
[TBL] [Abstract][Full Text] [Related]
17. Benzofuran Small Molecules as Potential Inhibitors of Human Protein Kinases. A Review.
Kwiecień H; Goszczyńska A; Rokosz P
Curr Pharm Des; 2016; 22(7):879-94. PubMed ID: 26648467
[TBL] [Abstract][Full Text] [Related]
18. PI3K inhibitors for cancer treatment: where do we stand?
Maira SM; Stauffer F; Schnell C; García-Echeverría C
Biochem Soc Trans; 2009 Feb; 37(Pt 1):265-72. PubMed ID: 19143644
[TBL] [Abstract][Full Text] [Related]
19. Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors.
Sharma S; Singh J; Ojha R; Singh H; Kaur M; Bedi PMS; Nepali K
Eur J Med Chem; 2016 Apr; 112():298-346. PubMed ID: 26907156
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the selectivity of kinase inhibitors in oncology: a chemical biology perspective.
Maddox S; Hecht D; Gustafson JL
Future Med Chem; 2016; 8(3):241-4. PubMed ID: 26898835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
